R&D

X ray illustration of a running person with pain in knee joint with blue background
Biotech

Novartis culls ph. 2 knee pain trial testing anti-ADAMTS-5 asset

Novartis discontinued the study after an interim analysis found an “insufficient effect on pain relief,” a spokesperson said.
Gabrielle Masson Apr 16, 2025 2:55pm
packing boxes moving layoffs failure shut down

Pfizer sells San Diego R&D site for $255M

Apr 10, 2025 11:06am
Blue race track

Relay starts 3rd layoff wave in one year, shedding 70 staffers

Apr 4, 2025 11:30am
Board room C-suite meeting contract

Sanofi snatches GSK R&D leader

Mar 31, 2025 1:26pm
A representation of golden gas or oil pipes surrounded with coins on financial graph with candle bars

Top 10 pharma R&D budgets in 2024

Mar 31, 2025 6:00am
biotechs top money raisers hero image

R&D cost per drug up year over year: Deloitte

Mar 25, 2025 12:01am